Ekso Bionics Holdings, Inc. (EKSO) Social Stream

Ekso Bionics Holdings, Inc. (EKSO): $0.67

0.02 (-2.90%)

POWR Rating

Component Grades








EKSO BIONICS HOLDINGS INC (EKSO) Price Targets From Analysts

The tables below show the price targets and recommendations analysts covering EKSO.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-03 2 $11 $9 $10 $0.69 1349.28%
2022-04-29 1 $11 $11 $11 $0.69 1494.2%
2023-07-28 1 $9 $9 $9 $0.69 1204.35%

Price Target Last Issued July 28, 2023

The Trend in the Analyst Price Target

Over the past 23 months, EKSO's average price target has gone down $2.

Over the past 120 days, EKSO's average upside potential has been 550.39%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2023-03-30 1 9 9 9 1.54 484.42%
2023-04-28 1 9 9 9 1.49 504.03%
2023-07-28 1 9 9 9 1.18 662.71%

EKSO Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1 1 0 0 0 0 1

The Trend in the Broker Recommendations

EKSO's average broker recommendation rating improved by 0 over the prior 15 months.

The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for EKSO as an investment opportunity.

  • In the context of all US stocks, EKSO BIONICS HOLDINGS INC's number of analysts covering the stock is greater than 6.12% of them.
  • EKSO has a higher upside potential (average analyst target price relative to current price) than 390.38% of all US stocks.
  • EKSO has a lower variance in analysts' estimates than 88.35% of Healthcare stocks.
  • In the context of Machinery stocks, EKSO BIONICS HOLDINGS INC's average analyst price target is higher than 19.21% of them.

Stocks similar to EKSO BIONICS HOLDINGS INC in the Machinery industry regarding analyst recommendations and price targets are TAYD, SDPI, and CVR.

Is EKSO a Buy, Hold or Sell? See the POWR Ratings now!

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!